news
2023-10-13 // Biden administration awards $500M for new COVID treatments
Go to Article
2023-10-11 // Pharma-backed MinervaX raises €54M as it aims to move its group B Streptococcus vaccine into PhIII
Go to Article
2023-10-09 // Antimicrobial resistance biotech secures $37M with ex-CureVac CEO Franz-Werner Haas at the helm
Go to Article
2023-10-09 // Gates Foundation spends $40M to boost mRNA vaccine production in Africa and beyond
Go to Article